US2020360339A1PendingUtilityA1

Formulation based on vitamin e or an ester thereof for treating bacterial and fungal biofilms

Assignee: BIO LO GA SRLPriority: May 29, 2017Filed: May 28, 2018Published: Nov 19, 2020
Est. expiryMay 29, 2037(~10.8 yrs left)· nominal 20-yr term from priority
Inventors:Giorgio Panin
A61K 31/355A61K 9/06A61P 31/10A61K 9/0014A61K 47/34A61K 47/14A61K 47/24A61P 31/04A61P 31/02
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Formulation for topical use based on vitamin E or an ester thereof for use in removing, reducing or inhibiting a bacterial and/or fungal biofilm, wherein said ester of vitamin E is an ester with a carboxylic acid of formula R—COOH, in which R is an alkyl radical having from 1 to 19 carbon atoms, or an alkenyl or alkynyl having from 2 to 19 carbon atoms.

Claims

exact text as granted — not AI-modified
1 . A method of removing, reducing or inhibiting a bacterial and/or fungal biofilm, which comprises topically applying a formulation consisting of vitamin E or an ester thereof. 
     
     
         2 . The method of  claim 1 , wherein said ester of vitamin E is an ester with a carboxylic acid of formula R—COOH, in which R is an alkyl radical having from 1 to 19 carbon atoms, or an alkenyl or alkynyl having from 2 to 19 carbon atoms. 
     
     
         3 . The method of  claim 2 , wherein said ester is alpha-tocopheryl acetate, n-propionate or linoleate. 
     
     
         4 . The method of  claim 3 , wherein said ester is alpha-tocopheryl acetate. 
     
     
         5 . The method of  claim 1 , wherein said formulation consists of vitamin E acetate. 
     
     
         6 . The method of  claim 1 , consists of alpha-tocopheryl acetate. 
     
     
         7 . A method of removing, reducing or inhibiting a bacterial and/or fungal biofilm, which comprises topically applying a formulation comprising in weight percentages on the total weight of the formulation, 20 to 70% of vitamin E acetate and 20 to 70% of a volatile silicone. 
     
     
         8 . The method of  claim 7 , wherein said volatile silicone is selected from the group consisting of pentamer cyclomethicone, tetramer cyclomethicone, hexamer cyclomethicone, hexamethyldisiloxane, low viscosity dimethicone and mixtures thereof. 
     
     
         9 . The method of  claim 8 , wherein said formulation further comprises 7 to 13% of hydrogenated castor oil by weight of the total weight of the formulation. 
     
     
         10 . The method of  claim 9 , wherein said formulation further comprises 7 to 15% by weight of the total weight of the formulation of an oily component selected from the group consisting of vegetable oils, esters of fatty acids selected from the group consisting of octyl palmitate, isopropyl myristate and ethyl oleate and mixtures thereof. 
     
     
         11 . The method of  claim 10 , wherein said formulation further comprises 2 to 3% of dimethiconol by weight of the total weight of the formulation.

Join the waitlist — get patent alerts

Track US2020360339A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.